- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06520215
Correlation Hand Grip Strength and Walking Distance in Elderly
December 16, 2024 updated by: Universitas Padjadjaran
Elderly patient post coronary revascularization assessed hand grip strength and changes in six minute walking distance
Study Overview
Status
Completed
Conditions
Detailed Description
Coronary artery disease causes muscle dysfunction which leads to decreased muscle fitness due to reduced cardiac output, resulting in reduced oxygen uptake from the blood, and further decreases functional capacity or maximum oxygen uptake.
The elderly population is an age group at risk of developing coronary artery disease.
Handgrip strength s a good predictor for assessing overall muscle fitness, where handgrip strength assessment with a dynamometer is one method of determining muscle fitness, one of the factors affecting cardiorespiratory fitness, which can be assessed by the 6-minute walk test.
This study wants to determine the correlation between handgrip strength and changes in 6-minute walk test after undergoing phase 2 cardiac rehabilitation in the elderly after coronary revascularization and this study also wants to know the predictive value using the parameters studied.
Study Type
Observational
Enrollment (Actual)
46
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
West Java
-
Bandung, West Java, Indonesia
- Hasan Sadikin Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patient above 60 years
Description
Inclusion Criteria:
- Post coronary revascularization
- MMSE >= 26 BMI 18.5-25
Exclusion Criteria:
- Comorbid cardiovascular, lung, kidney and metabolic disease
- Frailty Syndrome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation Between Hand Grip Strength and Walking Distance in Elderly Patients
Time Frame: 6 weeks
|
Elderly patient post coronary revascularization assessed hand grip strength (measured with hand dynamometer) and changes in six minute walking distance (measured in meter)
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Irma Ruslina Defi, Padjadjaran University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 25, 2024
Primary Completion (Actual)
September 5, 2024
Study Completion (Actual)
October 17, 2024
Study Registration Dates
First Submitted
July 20, 2024
First Submitted That Met QC Criteria
July 20, 2024
First Posted (Actual)
July 25, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 16, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- IKFR-202407.01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Revascularization
-
China National Center for Cardiovascular DiseasesCompletedCoronary Revascularization | Appropriate Use CriteriaChina
-
Samsung Medical CenterCompletedPercutaneous Coronary Intervention | Erythrocyte Transfusion | RevascularizationKorea, Republic of
-
Mohamed R El TahanNot yet recruitingElective Surgery | Minimally Invasive Coronary Revascularization SurgerySaudi Arabia
-
Samsung Medical CenterCompletedPercutaneous Coronary Intervention | Erythrocyte Transfusion | RevascularizationKorea, Republic of
-
China National Center for Cardiovascular DiseasesCompletedCoronary Revascularization | Syntax Score | AppropriatenessChina
-
Liu QiangNot yet recruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Myocardial Revascularization
-
Liu QiangZhejiang Provincial People's Hospital; The Third Affiliated hospital of Zhejiang... and other collaboratorsNot yet recruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Myocardial Revascularization
-
Liu QiangNot yet recruitingCoronary Artery Disease | Myocardial Revascularization | Postoperative Period
-
Joost DaemenHorizon 2020 - European Commission; REVA Medical, Inc.RecruitingPercutaneous Coronary Intervention | Tomography, Optical Coherence | Myocardial RevascularizationNetherlands, Belgium
-
Cardiocentro TicinoRecruitingCoronary Artery Disease | Antiplatelet Therapy | Minimally Invasive Coronary Revascularization SurgerySwitzerland